CIK 0001420800 · Large accelerated filer
Enovis CORP
Sign in to watch- Ticker
- ENOV
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541887631
- Phone
- (302) 252-9160
- Business address
- 2900 LAKE VISTA DRIVE, SUITE 200, LEWISVILLE, TX, 75067
- Former names
- Colfax CORP
- Open-market buys, last 90 days
- $599,541
- in 6 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$599,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-30 | Wienbar Sharon L Director | Grant or award | +492 | 29,275 | ||
| 2021-06-30 | Teirlinck Didier P Director | Grant or award | +492 | 25,547 | ||
| 2021-06-30 | PERFALL A CLAYTON Director | Grant or award | +601 | 51,277 | ||
| 2021-06-30 | GAYNER THOMAS SINNICKSON Director | Grant or award | +492 | 64,079 | ||
| 2021-06-30 | ALLENDER PATRICK W Director | Grant or award | +574 | 70,652 | ||
| 2021-06-21 | Trerotola Matthew L. President & CEO | Option exercise | +75,000 | $23.74 | $1.8M | 380,708 |
| 2021-06-21 | Trerotola Matthew L. President & CEO | Sale | −75,000 | $44.41 | $3.3M | 305,708 |
| 2021-06-21 | Trerotola Matthew L. President & CEO | Option exercise · Employee stock option (right to buy) | −75,000 | 284,563 | ||
| 2021-06-14 | Hix Christopher M EVP, Chief Financial Officer | Option exercise | +90,000 | $26.56 | $2.4M | 182,800 |
| 2021-06-14 | Hix Christopher M EVP, Chief Financial Officer | Sale | −89,900 | $45.89 | $4.1M | 92,900 |
| 2021-06-14 | Hix Christopher M EVP, Chief Financial Officer | Sale | −100 | $46.64 | $5K | 92,800 |
| 2021-06-14 | Hix Christopher M EVP, Chief Financial Officer | Option exercise · Employee stock option (right to buy) | −90,000 | 34,611 | ||
| 2021-05-14 | Trerotola Matthew L. President & CEO | Option exercise | +200,000 | $23.74 | $4.7M | 505,708 |
| 2021-05-14 | Trerotola Matthew L. President & CEO | Sale | −200,000 | $43.14 | $8.6M | 305,708 |
| 2021-05-14 | Trerotola Matthew L. President & CEO | Option exercise · Employee stock option (right to buy) | −200,000 | 359,563 | ||
| 2021-05-12 | PERFALL A CLAYTON Director | Grant or award | +3,294 | 50,676 | ||
| 2021-05-12 | Teirlinck Didier P Director | Grant or award | +3,294 | 25,055 | ||
| 2021-05-12 | Vinnakota Rajiv Director | Grant or award | +3,294 | 25,182 | ||
| 2021-05-12 | Kelly Liam Director | Grant or award | +3,294 | 12,918 | ||
| 2021-05-12 | ALLENDER PATRICK W Director | Grant or award | +3,294 | 70,078 |
Page 23 of 24 · 463 trades